GLP and G9a histone methyltransferases as potential therapeutic targets for lymphoid neoplasms

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversity of Brasília, Faculty of Health Sciences, Hematology and Stem Cells Laboratory-
Autor(es): dc.contributorUniversity of Brasília, Faculty of Health Sciences, Hematology and Stem Cells Laboratory-
Autor(es): dc.contributorUniversity of Brasília, Faculty of Health Sciences, Hematology and Stem Cells Laboratory-
Autor(es): dc.contributorUniversity of Brasilia, Faculty of Health Sciences and Medicine, Laboratory of Molecular Pathology of Cancer-
Autor(es): dc.contributorUniversity of Brasilia, Faculty of Health Sciences and Medicine, Laboratory of Molecular Pathology of Cancer-
Autor(es): dc.contributorUniversity of Brasília, Faculty of Health Sciences, Hematology and Stem Cells Laboratory-
Autor(es): dc.creatorCarvalho, Amandda Évelin Silva-
Autor(es): dc.creatorBraga, Luma Dayane Carvalho Filiú-
Autor(es): dc.creatorBogéa, Gabriela Muller Reche-
Autor(es): dc.creatorAssis, Alan Jhones Barbosa de-
Autor(es): dc.creatorSilva, Fábio Pittella-
Autor(es): dc.creatorAraujo, Felipe Saldanha-
Data de aceite: dc.date.accessioned2026-08-11T11:06:56Z-
Data de disponibilização: dc.date.available2026-08-11T11:06:56Z-
Data de envio: dc.date.issued2026-04-17-
Data de envio: dc.date.issued2026-04-17-
Data de envio: dc.date.issued2024-07-
Fonte completa do material: dc.identifierhttp://repositorio.unb.br/handle/10482/54300-
Fonte completa do material: dc.identifierhttps://doi.org/10.1186/s12935-024-03441-y-
Fonte completa do material: dc.identifierhttps://orcid.org/0000-0002-4200-0821-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/1187155-
Descrição: dc.descriptionHistone methyltransferases (HMTs) are enzymes that regulate histone methylation and play an important role in controlling transcription by altering the chromatin structure. Aberrant activation of HMTs has been widely reported in certain types of neoplastic cells. Among them, G9a/EHMT2 and GLP/EHMT1 are crucial for H3K9 methylation, and their dysregulation has been associated with tumor initiation and progression in different types of cancer. More recently, it has been shown that G9a and GLP appear to play a critical role in several lymphoid hematologic malignancies. Importantly, the key roles played by both enzymes in various diseases made them attractive targets for drug development. In fact, in recent years, several groups have tried to develop small molecule inhibitors targeting their epigenetic activities as potential anticancer therapeutic tools. In this review, we discuss the physiological role of GLP and G9a, their oncogenic functions in hematologic malignancies of the lymphoid lineage, and the therapeutic potential of epigenetic drugs targeting G9a/GLP for cancer treatment.-
Descrição: dc.descriptionFaculdade de Ciências da Saúde (FS)-
Descrição: dc.descriptionDepartamento de Farmácia (FS FAR)-
Descrição: dc.descriptionPrograma de Pós-Graduação em Ciências Farmacêuticas-
Formato: dc.formatapplication/pdf-
Idioma: dc.languageen-
Publicador: dc.publisherSpringer Nature-
Relação: dc.relationhttps://link.springer.com/article/10.1186/s12935-024-03441-y-
Direitos: dc.rightsAcesso Aberto-
Direitos: dc.rightsThe Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data-
Palavras-chave: dc.subjectLeucemia linfoblástica aguda (LLA)-
Palavras-chave: dc.subjectLeucemia linfocítica crônica (LLC)-
Palavras-chave: dc.subjectNeoplasmas-
Título: dc.titleGLP and G9a histone methyltransferases as potential therapeutic targets for lymphoid neoplasms-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional – UNB

Não existem arquivos associados a este item.